Analogue screening systems are gradually being replaced by digital mammography systems, and breast cancer screening programmes are increasing sales. The majority of European countries have implemented in European countries, but in some others their introduction is slow, but steady. Additionally, Europe has significant geographic diversity, and remote places served by mobile screening units…
22-26 May Milan, Italy
A new partnership between BreastHealth UK (BHUK) and Lab21 Ltd aims to offer women predictive genetic testing for breast cancer risk. BHUK, which offers personalised, private breast screening services, has launched a Breast Health Risk Assessment Service.
Many randomised trials have shown that endoscopic colonoscopies as well as virtual colonoscopies via CT scans are equally efficient in detecting colon polyps and tumours. With an endoscopic examination suspicious mucosal findings can be investigated by biopsy and polyps can be removed. However, causes for argument against this method include the incomplete examination, often severe pain and a…
Tissue removal is currently the only way to verify suspicious lesions in the prostate. It is also a key requirement before treating prostate carcinomas. The standard biopsy is performed with transrectal ultrasound (TRUS) to guide the needle in the right direction.
The Wound Care Unit at the Clinic Pasteur in Toulouse, France, was successfully set up to deliver a multidisciplinary approach to diabetic wound care.
Scientists have developed a new test for detecting kidney disease, according to a paper published online in April by Kidney International (www.nature.com/ki/). The technique will allow researchers and clinicians to identify kidney disease or injury within 15 minutes of testing in both rats and humans.
Definiens, the number one Enterprise Image Intelligence company, launched its first computer-aided detection (CAD) application, Definiens LymphExpert at the annual European Congress of Radiology (ECR) in Vienna, Austria. Now commercially available for European radiologists, the application assists in tracking lymph nodes of interest, facilitating earlier detection of the metastatic spread of…
A series of expert presentations organised by European Hospital in cooperation with the ECR addressed the latest issues affecting hospital management, information technology and fincance and attracted more than 400 attendees. Click here to read the summary of the five Management speeches.
Early detection currently remains the most promising way to optimise the diagnosis and treatment of breast cancer, lower the mortality rate resulting from this disease, and improve patients' quality of life.
SecondLook Digital from iCAD is Philips' new computer aided detection solution for early breast cancer detection. It supports physicians in identifying and marking suspicious areas. The software performs optimally with both Philips DR and CR mammography solution and seamlessly integrates in Philips PACS and Philips viewing workstation MammoDiagnost VU.
To date, there is insufficient knowledge as to the cause of this disease, or how to prevent it. We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.
Accreditation and standards of Excellence in Europe
The number of prostate cancer cases is increasing rapidly.
To date, there is insufficient knowledge as to the cause of this disease, or how to prevent it. We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.
To date, there is insufficient knowledge as to the cause of this disease, or how to prevent it. We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.
Current procedures are still imprecise and speculative; without a subsequent biopsy suspicious PSA levels, images and the results of palpation cannot be correctly evaluated. Thus there is an energetic pursuit to discover new imaging technologies. Dr Thilo Eggert at the Urological Clinic of the Ruhr University Bochum at the Marienhopital Herne, is among the investigators.
Cancer may well surpass cardiovascular diseases as the primary case of death in Europe by 2012. To prevent this from happening, cancer therapeutics have to shift in focus from the treatment of symptoms to offering a total cure, despite the complex, multifactorial nature of cancer indications.
Less acute heart attacks in Italy five months after the introduction of a smoking ban in indoor public places.
The lower life expectancy of men is mainly due to insufficient uptake of healthcare services and an unhealthy life style Low social status influences men's health far more than women's health Medical care must address men at work, at sports centres, and other gatherings
The University of Pittsburgh Medical Center and GE Healthcare plan to establish over 25 local cancer centres in various countries within the coming decade.
An innovative scheme using mobile technology to identify patients 'at risk# of developing CVD by effectively establishing smoking status has recently proved a great success for NHS Hammersmith and Fulham.
Lymph nodes play a critical role in the assessment of the spread of cancer, but identifying lymph nodes in surrounding tissue is a difficult task for most image analysis technology. German medical imaging company Definiens now introduced at RSNA 2008 its first computer-aided detection (CAD) application, Lymph Expert, that allows radiologists to identify and analyse lymph nodes volumetrically and…
Germans want a different healthcare system. 93% want individualised services — and they are prepared to pay for them, according to a study relating to the strategies of providers in Germany's healthcare system and their acceptance by the public.
There's little evidence that newer, more expensive drugs work any better than older, cheaper medications. Diabetes, which came 7th in the list of the USA's top mortality causes in 2006, has hit a new high.
